This inventor holds 1 USPTO granted patent. Top assignee: Kong Kook Pharmaceutical Co., Ltd.. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Ung Kil Jee: Innovator in Sustained Release Microparticles
Introduction
Ung Kil Jee is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained release microparticles. His innovative approach has the potential to enhance therapeutic effects for various medical applications.
Latest Patents
Ung Kil Jee holds a patent for a "Sustained release microparticle and method for preparing the same." This patent discloses a method for preparing sustained release microparticles that release a physiologically active substance over extended periods. The process involves a multi-emulsion technique where a drug of interest is dissolved or dispersed in at least two oils, each containing a biodegradable polymer. The resulting microparticles allow for the continuous release of drugs, such as leutenizing hormone-releasing hormones, improving therapeutic outcomes.
Career Highlights
Ung Kil Jee is associated with Kong Kook Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical innovations. His work focuses on developing advanced drug delivery systems that can significantly impact patient care and treatment efficacy.
Collaborations
He collaborates with esteemed colleagues, including Il Ho Lim and Goo Young Jung, to further enhance the research and development of innovative pharmaceutical solutions.
Conclusion
Ung Kil Jee's contributions to the field of sustained release microparticles exemplify the importance of innovation in pharmaceuticals. His work not only advances drug delivery systems but also holds promise for improving patient outcomes in various therapeutic areas.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile